From foods and agriculture, to pharmaceuticals and medical care, to consumer products and automobile safety, few policy issues are as important to the public as the regulation of health and safety. People often rely on government regulators to assure the safety and quality of many of the products they use and consume, but government regulation can often compromise safety, quality, affordability, and choice if it focuses on a fear-driven activist agenda rather than basic principles of science and risk-balancing. Too often, the government’s regulatory agenda favors politically expedient outcomes over those that would actually promote safety and availability. Safety and health regulations should be designed with maximum flexibility to allow producers to use the production methods and labeling information that best meets their customers’ demands.
Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…